Depakene and Tylenol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Depakene (valproic acid) and Tylenol (acetaminophen). Common drug interactions include dyspnoea among females and loss of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Depakene and Tylenol. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Depakene?

Depakene has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 14,776 Depakene users. Check the latest studies of Depakene.

What is Tylenol?

Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,310 Tylenol users. Check the latest studies of Tylenol.



On Aug, 05, 2026

77 people who take Depakene and Tylenol together, and have interactions are studied.

Depakene and Tylenol drug interactions.

What are the common drug interactions of Depakene and Tylenol, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fall
  3. Hypovolaemia (a decreased volume of circulating blood in the body)
  4. Lethargy (tiredness)
  5. Menopause (end of monthly cycles in women)
  6. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  7. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  8. Urinary retention (the inability to completely or partially empty the bladder)
  9. Vomiting
  10. Asthenia (weakness)

male:

  1. Loss of consciousness
  2. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  3. Fall
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Renal failure (kidney dysfunction)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Antisocial personality disorder
  8. Arthralgia (joint pain)
  9. Asthenia (weakness)
  10. Back pain

What are the common drug interactions of Depakene and Tylenol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Muscular weakness (muscle weakness)
  3. Pneumonia
  4. Anticonvulsant drug level below therapeutic
  5. Blood glucose increased
  6. Cardiac arrest
  7. Dehydration (dryness resulting from the removal of water)
  8. Hypovolaemia (a decreased volume of circulating blood in the body)
  9. Lethargy (tiredness)
  10. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)

10-19:

  1. Hypersomnia (excessive daytime sleepiness (eds))
  2. Pneumonia
  3. Abdominal discomfort
  4. Diarrhoea
  5. Nausea (feeling of having an urge to vomit)
  6. Abdominal distension
  7. Influenza
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Urinary tract infection
  10. Adverse drug reaction

20-29:

  1. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  2. Acute respiratory failure
  3. Asthenia (weakness)
  4. Drug ineffective
  5. Dry eye (lack of adequate tears)
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Inflammation
  8. Oral disorder (mouth disease)
  9. Pigmentation disorder (disturbances of human skin colour)
  10. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

30-39:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Antisocial personality disorder
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Back pain
  7. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Depressed mood
  10. Disturbance in attention

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bacterial test positive
  4. Blindness
  5. Blood creatine phosphokinase increased
  6. Brain injury
  7. Cardiac arrest
  8. Cerebral artery occlusion (blockage of blood vessel of brain by fat or clot)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Conjunctivitis (pink eye)

50-59:

  1. International normalised ratio increased
  2. Blood potassium decreased
  3. Blood pressure decreased
  4. Calculus bladder (bladder stone)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Diarrhoea
  7. Dyskinesia (abnormality or impairment of voluntary movement)
  8. Fall
  9. Hyperadrenalism (excessive levels of adrenal hormones in the body)
  10. Leukopenia (less number of white blood cells in blood)

60+:

  1. Fall
  2. Back pain
  3. Abdominal pain upper
  4. Adrenal mass
  5. Agitation (state of anxiety or nervous excitement)
  6. Cough
  7. Dementia (madness)
  8. Ear pain
  9. Essential hypertension (primary hypertension)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the existing conditions these people have? *

  1. Fever: 17 people, 22.08%
  2. Headache (pain in head): 11 people, 14.29%
  3. Constipation: 11 people, 14.29%
  4. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 10 people, 12.99%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 12.99%
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 9 people, 11.69%
  7. Nausea (feeling of having an urge to vomit): 8 people, 10.39%
  8. Insomnia (sleeplessness): 8 people, 10.39%
  9. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 8 people, 10.39%
  10. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 7 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Depakene and Tylenol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Depakene and Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Depakene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Depakene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tylenol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valproic acid and acetaminophen (the active ingredients of Depakene and Tylenol, respectively), and Depakene and Tylenol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: